Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema

NACompletedINTERVENTIONAL

Enrollment

170

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

May 31, 2007

Conditions

Melanoma

Interventions

DRUG

Sub-Tenon triamcinolone 40mg

Trial Locations (1)

Ocular Oncology Service, Wills Eye Institute, Philadelphia

All Listed Sponsors

lead

Wills Eye

OTHER

NCT00441662 - Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema | Biotech Hunter | Biotech Hunter